Contact this trialFirst, we need to learn more about you.
Proteasome Inhibitor
Selinexor Combination Therapy for Multiple Myeloma
Recruiting1 awardPhase 2
Westerly, Rhode Island
This trial is comparing a new combination of drugs called Dara-SVD to the standard treatment of Dara-RVD for patients with high-risk newly diagnosed multiple myeloma. The new combination includes a
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service